Professor | 潘晓彦 | 数字化转型顾问

	Upload Avatar (500 x 500)
Name	潘晓彦
Contact Information	panxy@wh.iov.cn
Language ability	中文, 英语
Province	湖北

Upload Avatar (500 x 500)

Name

潘晓彦

Contact Information

panxy@wh.iov.cn

Language ability

中文, 英语

Province

湖北

University/Lab Affiliation and Title	中国科学院大学
Faculty	Life Sciences
Academic Background & Achievements	2011-09--2016-06 博士: 南方医科大学成就 1: 青年年度人物, 2020 成就 2: 优秀毕业生, 2016
Work Experience	2020-09~现在 - 中国科学院武汉病毒研究所 - 副研究员 2018-08~2020-09 - 中国科学院武汉病毒研究所 - 助理研究员 2016-08~2018-08 - 中国科学院武汉病毒研究所 - 博士后 2011-09~2016-06 - 南方医科大学 - 博士
Awards	青年年度人物 (2020): 研究所优秀毕业生 (2016): 研究所

University/Lab Affiliation and Title

中国科学院大学

Faculty

Life Sciences

Academic Background & Achievements

2011-09--2016-06 博士: 南方医科大学
成就 1: 青年年度人物, 2020
成就 2: 优秀毕业生, 2016

Work Experience

2020-09~现在 - 中国科学院武汉病毒研究所 - 副研究员
2018-08~2020-09 - 中国科学院武汉病毒研究所 - 助理研究员
2016-08~2018-08 - 中国科学院武汉病毒研究所 - 博士后
2011-09~2016-06 - 南方医科大学 - 博士

Awards

青年年度人物 (2020): 研究所
优秀毕业生 (2016): 研究所

Areas of Focus	疫苗小分子药物治疗性抗体
Publications	Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB, 第2作者, 2023 Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2, 第2作者, 2023 Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants, 第11作者, 2023 Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation, 第1作者, 2022 Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein, 第11作者, 2022 CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, 第10作者, 2022 High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors, 第23作者, 2022 Why is the SARS-CoV-2 Omicron variant milder?, 第3作者, 2022 PARP1 Might Substitute HSF1 to Reactivate Latent HIV-1 by Binding to Heat Shock Element, 第9作者, 2022 Identification, optimization, and biological evaluation of 3-O-β-chacotriosyl ursolic acid derivatives as novel SARS-CoV-2 entry inhibitors by targeting the prefusion state of spike protein, 未提及, 2022 SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target, 第4作者, 2021 SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO, 第3作者, 2021 A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates, 第4作者, 2021 Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses, 第2作者, 2021 Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID-19 by Blocking SARS-CoV-2 Spike Protein-Mediated Membrane Fusion, 第2作者, 2021 Antiviral Bafilomycins from a Feces-Inhabiting Streptomyces sp., 第3作者, 2021 Axial Chiral Binaphthoquinone and Perylenequinones from the Stromata of Hypocrella bambusae Are SARS-CoV-2 Entry Inhibitors, 第11作者, 2021 High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors, 第4作者, 2021 The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids, 第4作者, 2020 Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein, 第2作者, 2020 Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junin virus, 第1作者, 2020 Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro, 第1作者, 2020 Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein, 第5作者, 2019 Heat shock factor 1 suppresses the HIV-induced inflammatory response by inhibiting nuclear factor-κB, 第1作者, 2018

Areas of Focus

疫苗
小分子药物
治疗性抗体

Publications

Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB, 第2作者, 2023
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2, 第2作者, 2023
Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants, 第11作者, 2023
Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation, 第1作者, 2022
Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein, 第11作者, 2022
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, 第10作者, 2022
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors, 第23作者, 2022
Why is the SARS-CoV-2 Omicron variant milder?, 第3作者, 2022
PARP1 Might Substitute HSF1 to Reactivate Latent HIV-1 by Binding to Heat Shock Element, 第9作者, 2022
Identification, optimization, and biological evaluation of 3-O-β-chacotriosyl ursolic acid derivatives as novel SARS-CoV-2 entry inhibitors by targeting the prefusion state of spike protein, 未提及, 2022
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target, 第4作者, 2021
SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO, 第3作者, 2021
A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates, 第4作者, 2021
Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses, 第2作者, 2021
Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID-19 by Blocking SARS-CoV-2 Spike Protein-Mediated Membrane Fusion, 第2作者, 2021
Antiviral Bafilomycins from a Feces-Inhabiting Streptomyces sp., 第3作者, 2021
Axial Chiral Binaphthoquinone and Perylenequinones from the Stromata of Hypocrella bambusae Are SARS-CoV-2 Entry Inhibitors, 第11作者, 2021
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors, 第4作者, 2021
The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids, 第4作者, 2020
Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein, 第2作者, 2020
Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junin virus, 第1作者, 2020
Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro, 第1作者, 2020
Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein, 第5作者, 2019
Heat shock factor 1 suppresses the HIV-induced inflammatory response by inhibiting nuclear factor-κB, 第1作者, 2018

免疫传染病病毒感染药物开发抗病毒剂生物制药临床试验分子生物学生物技术治疗学

钱旻 - 华东师范大学

赵春华 - 上海大学

刘畅 - 上海大学

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们